6w5h: Difference between revisions

← Older edit

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
-The entry 6w5h is ON HOLD  until Paper Publication
+==1.85 A resolution structure of Norovirus 3CL protease in complex with inhibitor 5d==
+<StructureSection load='6w5h' size='340' side='right'caption='[[6w5h]], [[Resolution|resolution]] 1.85&Aring;' scene=''>
+== Structural highlights ==
+<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6W5H OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6W5H FirstGlance]. <br>
+</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.85&#8491;</td></tr>
+<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=TKP:2-(3-chlorophenyl)-2-methylpropyl+[(2S)-3-cyclohexyl-1-({(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)-1-oxopropan-2-yl]carbamate'>TKP</scene></td></tr>
+<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6w5h FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6w5h OCA], [https://pdbe.org/6w5h PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6w5h RCSB], [https://www.ebi.ac.uk/pdbsum/6w5h PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6w5h ProSAT]</span></td></tr>
+</table>
+<div style="background-color:#fffaf0;">
+== Publication Abstract from PubMed ==
+Acute gastroenteritis caused by noroviruses has a major impact on public health worldwide in terms of morbidity, mortality, and economic burden. The disease impacts most severely immunocompromised patients, the elderly, and children. The current lack of approved vaccines and small-molecule therapeutics for the treatment and prophylaxis of norovirus infections underscores the need for the development of norovirus-specific drugs. The studies described herein entail the use of the gem-dimethyl moiety as a means of improving the pharmacological activity and physicochemical properties of a dipeptidyl series of transition state inhibitors of norovirus 3CL protease, an enzyme essential for viral replication. Several compounds were found to be potent inhibitors of the enzyme in biochemical and cell-based assays. The pharmacological activity and cellular permeability of the inhibitors were found to be sensitive to the location of the gem-dimethyl group.
-Authors: Lovell, S., Kashipathy, M.M., Battaile, K.P., Rathnayake, A.D., Kim, Y., Chang, K.O., Groutas, W.C.
+Structure-Guided Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease.,Rathnayake AD, Kim Y, Dampalla CS, Nguyen HN, Jesri AM, Kashipathy MM, Lushington GH, Battaile KP, Lovell S, Chang KO, Groutas WC J Med Chem. 2020 Sep 18. doi: 10.1021/acs.jmedchem.0c01252. PMID:32945669<ref>PMID:32945669</ref>
-Description: 1.85 A resolution structure of Norovirus 3CL protease in complex with inhibitor 5d
+From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-[[Category: Unreleased Structures]]
+</div>
-[[Category: Groutas, W.C]]
+<div class="pdbe-citations 6w5h" style="background-color:#fffaf0;"></div>
-[[Category: Battaile, K.P]]
-[[Category: Chang, K.O]]
+==See Also==
-[[Category: Kashipathy, M.M]]
+*[[Virus protease 3D structures|Virus protease 3D structures]]
-[[Category: Kim, Y]]
+== References ==
-[[Category: Lovell, S]]
+<references/>
-[[Category: Rathnayake, A.D]]
+__TOC__
+</StructureSection>
+[[Category: Large Structures]]
+[[Category: Battaile KP]]
+[[Category: Chang KO]]
+[[Category: Groutas WC]]
+[[Category: Kashipathy MM]]
+[[Category: Kim Y]]
+[[Category: Lovell S]]
+[[Category: Rathnayake AD]]